Exagen Inc. (XGN)
NASDAQ · Healthcare
Exagen Inc. Long Term Debt 2018–2025
Exagen Inc. annual/quarterly long term debt history from 2018 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Exagen Inc. long term debt for the quarter ending December 31, 2025 were 22.9M, a 13.15% increase year-over-year.
- Exagen Inc. long term debt for 2025 were 22.9M, a 13.15% increase from 2024.
- Exagen Inc. long term debt for 2024 were 20.2M, a 3.85% increase from 2023.
- Exagen Inc. long term debt for 2023 were 19.5M, a 32.70% decrease from 2022.
- Exagen Inc. long term debt for 2022 were 29.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Exagen Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $23 |
| 2024 | $20 |
| 2023 | $19 |
| 2022 | $29 |
| 2021 | $27 |
| 2020 | $27 |
| 2019 | $26 |
| 2018 | $25 |
| Exagen Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $23 |
| 2024-12-31 | $20 |
| 2023-12-31 | $19 |
| 2022-12-31 | $29 |
| 2021-12-31 | $27 |
| 2020-12-31 | $27 |
| 2019-12-31 | $26 |
| 2018-12-31 | $25 |
Exagen Inc. Long Term Debt — FAQ
Exagen Inc. (XGN) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XGN's long term debt history?
The chart and table above show Exagen Inc.'s long term debt by year and by quarter, including the growth rate.